Fibrocystic Breast Disease
📧 Sign up to get email alerts when something new happens for Fibrocystic Breast Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases [Phase 4]
Phase 4 trial update exploring a phytomedicine as monotherapy for fibrocystic breast disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses [EARLY_Phase 1]
An early-phase trial compares breast tomosynthesis mammography with conventional imaging to characterize breast masses; the study has comple…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease [Phase 3]
This report indicates completion of a Phase 3 trial evaluating the efficacy and safety of ONCOXIN in patients with fibrocystic breast diseas…
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
Clinical trial NCT00310882 has been withdrawn; it investigated the involvement of endogenous digitalis-like compounds in breast cancer.
-
CLINICAL_TRIALS research · 2007-06-18Clinical Trial Update: Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain [Phase 3]
A Phase 3 trial for cyclic breast pain associated with fibrocystic breast disease is being conducted, sponsored by Symbollon Pharmaceuticals…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-04-19FDA Approved: DANAZOL — Original Application (Lannett Company, Inc.)
FDA approved the original application for the generic Danazol (DANAZOL) from Lannett Company, Inc. Indications include endometriosis, heredi…